Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 9475 questions Show Answers
To ask the Scottish Government, regarding its draft Budget 2026-27 and the associated level 4 tables, whether it will provide a detailed breakdown of the £21.163 million committed to long-term conditions.
To ask the Scottish Government, regarding its draft Budget 2026-27 and the associated level 4 tables, whether it will provide a detailed breakdown of the £245.081 million in funding allocated to the Primary Care Fund.
To ask the Scottish Government how much has been provided to local authorities to address delayed discharges, broken down by local authority, in each of the last five years.
To ask the Scottish Government, further to the Scottish Spending Review 2026, what savings are expected in each year from each (a) territorial and (b) special NHS board to achieve the savings of £247 million in 2026-27, £290 million in 2027-28 and £220 million in 2028-29.
To ask the Scottish Government whether it has a strategy for (a) the conservation of and (b) investment in country parks.
To ask the Scottish Government what planning applications called in by the Scottish Ministers for consideration in the last five years have been subject to public hearings.
To ask the Scottish Government what funding it provides for country parks.
To ask the Scottish Government how many country parks there are in Scotland, and who (a) owns and (b) manages each.
To ask the Scottish Government, further to the answer to question S6W-38776 by Ivan McKee on 11 July 2025, whether it will provide an update on what planning applications called in by the Scottish Ministers have yet to be determined, and when they were first submitted for consideration.
To ask the Scottish Government what action it will take to align Scotland's access to innovative genomic breast cancer diagnostics with the rest of the UK and other northern European countries, which already routinely use genomic tests to more accurately target treatment for postmenopausal lymph node-positive breast cancer patients, with a view to ensuring that patients in Scotland benefit from the same advances in evidence-based treatments and innovations.